These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial. Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Novak V; Milberg W; Hao Y; Munshi M; Novak P; Galica A; Manor B; Roberson P; Craft S; Abduljalil A Diabetes Care; 2014; 37(3):751-9. PubMed ID: 24101698 [TBL] [Abstract][Full Text] [Related]
10. Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review. Avgerinos KI; Kalaitzidis G; Malli A; Kalaitzoglou D; Myserlis PG; Lioutas VA J Neurol; 2018 Jul; 265(7):1497-1510. PubMed ID: 29392460 [TBL] [Abstract][Full Text] [Related]
11. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Djupesland PG Neurology; 2008 Sep; 71(11):864; author reply 864. PubMed ID: 18779519 [No Abstract] [Full Text] [Related]
12. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments. Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944 [TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease. Stein MS; Scherer SC; Ladd KS; Harrison LC J Alzheimers Dis; 2011; 26(3):477-84. PubMed ID: 21694461 [TBL] [Abstract][Full Text] [Related]
14. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial. Schmidt H; Kern W; Giese R; Hallschmid M; Enders A J Med Genet; 2009 Apr; 46(4):217-22. PubMed ID: 18948358 [TBL] [Abstract][Full Text] [Related]
15. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence. Freiherr J; Hallschmid M; Frey WH; Brünner YF; Chapman CD; Hölscher C; Craft S; De Felice FG; Benedict C CNS Drugs; 2013 Jul; 27(7):505-14. PubMed ID: 23719722 [TBL] [Abstract][Full Text] [Related]
16. Intranasal Insulin for Alzheimer's Disease. Hallschmid M CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428 [TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder. McIntyre RS; Soczynska JK; Woldeyohannes HO; Miranda A; Vaccarino A; Macqueen G; Lewis GF; Kennedy SH Bipolar Disord; 2012 Nov; 14(7):697-706. PubMed ID: 23107220 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Intranasal Insulin in Improving Cognition in Mild Cognitive Impairment and Alzheimer Disease: A Systematic Review and Meta-analysis. Lu J; Xu Z Am J Ther; 2019; 26(6):e756-e762. PubMed ID: 30648990 [No Abstract] [Full Text] [Related]
19. No effect of single-dose intranasal insulin treatment on verbal memory and sustained attention in patients with schizophrenia. Fan X; Copeland PM; Liu EY; Chiang E; Freudenreich O; Goff DC; Henderson DC J Clin Psychopharmacol; 2011 Apr; 31(2):231-4. PubMed ID: 21346605 [TBL] [Abstract][Full Text] [Related]
20. Insulin and cognitive function in humans: experimental data and therapeutic considerations. Strachan MW Biochem Soc Trans; 2005 Nov; 33(Pt 5):1037-40. PubMed ID: 16246040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]